Trial
NCT02047019
Monotherapy-Controlled Study of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Combination in Subjects With Essential Hypertension Inadequately Controlled on Candesartan Cilexetil
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Bayer
Collaborators
—
Condition
Hypertension
Intervention
Nifedipine GITS/Candesartan Cilexetil FDC(BAY98-7106)
Why stopped
GPDC decided to terminate the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-05-22